Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEA vs iv-PCA for Bowel Recovery in Upper Abdominal Surgery
NCT02491385Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2014
- Primary completion
- Mar 2015
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of hydromorphone and ropivacaine hydrochloride liposomal suspension injection in postoperative ileus (POI) and postoperative pain (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Time to first gas-out at 10 days. Started Apr 2014; status: completed.
02
Drugs
hydromorphoneropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative ileus (POI)postoperative pain
Beyond the preview
Go deeper on NCT02491385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491385.